Treatment
Levosimendan clinical trials
We’re tracking 5 recruiting studies that include Levosimendan, each written for real people, not researchers, below.
Recruiting studies
- NCT07105202RecruitingPhase 4
Shorter weaning from ventilator with levosimendan
This study tests if a heart medication called levosimendan helps people get off the breathing machine (ventilator) faster. It's for people who have been on a ventilator for more than 48 hours and have already tried and failed to breathe on their own.
Arnhem, GelderlandAges 18 years+ - NCT04020263RecruitingPhase 3
Levosimendan early treatment vs placebo for cardiogenic shock
This study tests whether giving levosimendan early (a heart-strengthening medicine) improves outcomes compared with placebo, on top of standard inotropic support, in people with cardiogenic shock. It mainly looks at whether patients have fewer serious complications or deaths.
Strasbourg, Bas-RhinAges 18 years+ - NCT05664191RecruitingPhase 2
Levosimendan for brain bleeding from a ruptured aneurysm
This Phase 2 study tests whether the medicine levosimendan can improve outcomes after a ruptured aneurysm causing bleeding around the brain. It is designed for certain grades of severity in the first hospital days in the surgical intensive care unit.
Paris, FranceAges 18–75 - NCT07436689Enrolling by invitationPhase 3
Long-term study of oral levosimendan for heart failure
This long-term study gives continued access to the oral levosimendan medication for people who finished the earlier TNX-103 study. The goal is to see if ongoing treatment remains safe and helpful.
Chicago, IllinoisAges Any age - NCT07288398RecruitingPhase 3
Levosimendan for exercise limitation in PH-HFpEF
This trial tests if the drug levosimendan can help people with a specific type of pulmonary hypertension (PH-HFpEF) feel less tired and breathless during daily activities, and improve their exercise ability.
Alexander City, AlabamaAges 18–85
What Levosimendan is being studied for
Conditions with recruiting Levosimendan studies.
Common questions
- Are there clinical trials studying Levosimendan?
- Yes. Clin2 currently lists 5 recruiting studies that include Levosimendan, drawn from the U.S. registry and rewritten for real people so you can see what each is testing and who it's for.
- How do I know if I qualify for a Levosimendan trial?
- Each study lists its own eligibility criteria — rules about condition, age, and prior treatments. On every Clin2 trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Is Levosimendan an approved treatment?
- A drug being studied in a trial may be investigational (still being tested) or already approved and being studied for a new use. Each study page explains what phase it's in. Clin2 does not provide medical advice — talk with your doctor about whether Levosimendan or a specific trial is right for you.
Related treatments
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. A drug appearing here is being studied in a trial and may be investigational. Talk with your doctor about whether a specific treatment or trial is right for you.